BR vs LIMNW
Broadridge Financial Solutions Inc (BR) versus Liminatus Pharma, Inc. Warrants (LIMNW) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
LIMNW does not have a complete income-statement cache yet.
BR currently screens at market cap $17.65B and trailing P/E 16.3. LIMNW currently screens at market cap $0.
Not investment advice. Open the BR and LIMNW stock pages for the full models.
Not investment advice.